Multiply Labs raises $75 million in a Series B led by medical researcher Patrick Soon-Shiong, with AstraZeneca and robotics maker Teradyne among more than half a dozen other backers. Its robotics clusters use robotic arms, specialized enclosures and customer-trained AI to automate pharmaceutical production steps while imitating existing manual workflows. The company focuses on cell and gene therapies, says its technology can increase throughput 100-fold and lower cost per dose by 74%, and plans to expand therapy support and production capacity.
Promise Bio emerges from stealth with an $8.3 million seed round backed by lead investor Awz Ventures and strategic investors Pfizer and AstraZeneca. The Tel Aviv biotech has developed a cloud-based AI platform that detects post-translational protein modifications from a single blood sample, aiming to support precision medicine for autoimmune diseases. It works with hospitals in the U.S. and Israel and plans to use the funding to hire and build a database of PTM data.
